BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 134608)

  • 1. [Flow fluorescence-photometry in ovarian carcinomas with and without effusion].
    Krug H; Ebeling K
    Zentralbl Gynakol; 1976; 98(7):410-7. PubMed ID: 134608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor diagnosis in pleural and ascitic effusions based on DNA cytophotometry.
    Freni SC; James J; Prop FJ
    Acta Cytol; 1971; 15(2):154-62. PubMed ID: 4103817
    [No Abstract]   [Full Text] [Related]  

  • 3. [The characterisation of malignant ovarian tumors by impulse cytophotometry (author's transl)].
    Krug H; Ebeling K
    Arch Geschwulstforsch; 1976; 46(3):214-24. PubMed ID: 971042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytologic study of ascitic and pleural fluid in patients with malignant ovarian tumors for diagnostic and prognostic purposes].
    Aĭnbinder NM; Nechaeva ID; Ptokhov MP
    Vopr Onkol; 1965; 11(8):31-7. PubMed ID: 5887835
    [No Abstract]   [Full Text] [Related]  

  • 6. Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors.
    Kleinberg L; Pradhan M; Tropé CG; Nesland JM; Davidson B; Risberg B
    Diagn Cytopathol; 2008 Sep; 36(9):637-44. PubMed ID: 18677760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impulse cytophotometry and catamnesis in breast neoplasms].
    Krug H; Schönfelder M
    Acta Histochem Suppl; 1984; 30():117-27. PubMed ID: 6425932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of directed cytological examinations in the diagnosis of ovarian tumors].
    Pajtler M; Cugalj B; Milojković M; Makarović Z
    Jugosl Ginekol Perinatol; 1989; 29(3-4):133-6. PubMed ID: 2601367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.
    Davidson B; Espina V; Steinberg SM; Flørenes VA; Liotta LA; Kristensen GB; Tropé CG; Berner A; Kohn EC
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):791-9. PubMed ID: 16467090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy of ovarian and adnexal cyst fluid. A useful adjunct to cytology.
    Greenebaum E; Yee HT; Liu J
    Acta Cytol; 1994; 38(2):201-8. PubMed ID: 8147211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impulse cytophotometric investigations on melanoblastoma (author's transl)].
    Krug H; Schönfelder M
    Arch Geschwulstforsch; 1975; 45(4):347-67. PubMed ID: 1200781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse cytophotometric measurements on tumor cell suspensions and exfoliative material.
    Krug H
    Arch Geschwulstforsch; 1978; 48(2):145-9. PubMed ID: 686979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant effusions: from diagnosis to biology.
    Davidson B
    Diagn Cytopathol; 2004 Oct; 31(4):246-54. PubMed ID: 15452897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impulse cytophotometric investigations on tumour material (author's transl)].
    Krug H
    Arch Geschwulstforsch; 1976; 46(2):110-5. PubMed ID: 60982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.